Over the last couple of years, AI and blockchain have made inroads into the life sciences industry, including the pharmaceutical supply chain network. What was once considered a tedious task spanning multiple departments and involving countless stakeholders is now on the brink of complete automation.
However, AI and blockchain technologies go far beyond improving the efficiency of procurement operations. With stricter regulatory requirements, global supply disruptions, and the growing threat of counterfeit drugs making their way to the market, digitalization is becoming a strategic necessity.
Digitalization in pharma procurement combines AI-driven demand forecasting, blockchain-based traceability, IoT-enabled monitoring, and workflow automation to create a transparent, reliable, and compliant procurement process in the pharmaceutical sector.
In this article, we will discuss exactly that. We’ll start off by exploring how AI forecasting and blockchain traceability are transforming pharmaceutical procurement. We will also examine the benefits of adapting these technologies for both buyers and suppliers, the challenges associated with adoption, and the best practices for fully embracing this digital transformation without compromising compliance.
Current Challenges in Pharma Procurement
Forecasting Inaccuracy and Demand Volatility
One of the most persistent problems in pharmaceutical procurement is poor demand forecasting. And there’s considerable data to back this up:
Studies show that the supply chain network of pharma companies often struggles with inaccurate forecasting, long lead times, stockouts, overstocking, and staggering supply chain costs.
In another study conducted on Ethiopia’s public pharmaceutical supply system, researchers found that procurement delays were compounded by inaccurate forecasts due to workforce shortage and weak data quality.
This is where AI-driven forecasting comes in.
AI-powered demand forecasting refers to the utilization of machine learning algorithms to study historical data, incorporating real-time data to make precise predictions, and adapting to changing market conditions through continuous learning. For example, a 2022 study on machine learning in pharma supply chains reported that advanced forecasting models can improve accuracy by 10% to 41%, reducing costly mismatches between supply and demand.
Counterfeit and Substandard Medicines
Another challenge that the pharma procurement system faces is the widespread prevalence of counterfeit and falsified medicines. According to the World Health Organization (WHO),1 in every 10 medical products in low- and middle-income countries are substandard or falsified, costing health systems over US$30 billion annually.
And this is where foolproof traceability systems take the plunge: blockchain traceability systems are filling this void by providing immutable, end-to-end visibility of every drug’s origin, movement, and handling.
Regulatory Compliance and Traceability Gaps
Pharmaceutical procurement operates under some of the strictest regulatory requirements in the world, yet many systems lack the traceability needed for full compliance. Blockchain technology provides tamper-proof audit trails and enables compliance with serialization laws and Good Distribution Practices. Once this tech is fully adopted, procurement teams will no longer have to deal with fragmented data systems, manual paperwork, and difficulties in proving regulatory adherence across borders.
Supply Chain Disruptions and Drug Shortages
Drug shortages remain a visible symptom of weak procurement systems, causing shortages in around 10% of essential drugs with potential reductions to 4-5% if supply chain resilience improves.
Apart from supply chain disruptions, compromised procurement systems also struggle with cold chain management. This is again where AI forecasting and IoT come in handy:
AI forecasting can help mitigate drug shortages by predicting supply–demand mismatches way early, while blockchain and IoT integration can enable procurement teams to monitor temperature-sensi...
(All Rights Reserved)